THELOGICALINDIAN - This is a paid columnist absolution which contains advanced attractive statementsand should be advised as announcement or promotional actual Bitcoincom does not endorse nor abutment this productservice Bitcoincom is not amenable for or accountable for any agreeable accurateness or affection aural the columnist release
Jaron Lukasiewicz joins as Strategic Advisor in beforehand of September Token Sale
Zug, Switzerland and Boston, — MA August 15, 2024 — Ambrosus, the world’s aboriginal trusted blockchain-based ecosystem for the accumulation chain, has appear a affiliation with biologic avant-garde Trek Therapeutics, PBC (Trek) to administer chip sensors accompanying with blockchain-based technology to biologic biologic accomplishment in Trek’s analytic development program. This advertisement comes as blockchain industry ample Jaron Lukasiewicz joins Ambrosus as Strategic Advisor.
Combining high-tech sensors, blockchain, and powered by acute contracts, Ambrosus is architecture the world’s aboriginal publicly-verifiable, community-driven ecosystem to ensure the quality, safety, and origins of capital products, such as medicine, aliment and commodities. As allotment of the collaboration, Ambrosus will conduct pilot projects with Trek to adviser the quality, assurance and candor of all stages of the biologic accomplishment process.
Trek Co-founder and CEO Dr. Ann Kwong said, “Currently the biologic accomplishment action is awful adapted by biologic manufacturers and by authoritative authorities in an acutely labor-intensive and big-ticket manner. We achievement to accomplice with Ambrosus to actualize a connected ecology and tracking arrangement that will be beneath activity intensive, beneath expensive, and added cellophane to all parties with a pale in affection biologic manufacturing. Our ambition is to advance a arrangement that is able-bodied abundant that Trek can abide abstracts to abutment our accomplishment appliance for authoritative approval of our drugs from the FDA and EMA authorities.”
“Additionally, patients currently accept no way to ascertain the affection of the medicines they ingest. Trek believes it is important to be able to authenticate to patients that while our drugs are affordable, they’re additionally of the accomplished quality,” Dr Kwong added.
Ambrosus Co-Founder and CEO Angel Versetti said, “Following the acknowledged accomplishing of the Ambrosus agreement in all-around aliment accumulation chains, we are captivated to now administer our blockchain agreement to advice ensure the quality, assurance and candor of addition awfully important artefact – pharmaceuticals.”
Trek Therapeutics, PBC is a privately-held, public-benefit association developing treatments for austere infections. Its mission is to accommodate cost-effective, affordable, and attainable medicines to amusement patients that ache from communicable diseases and commercialize them for all-around populations. Since the company’s founding in 2024, Trek has aloft US$10M in Series A funding. Trek’s administration aggregation and lath of admiral is comprised of acclimatized drug-development admiral from Vertex, Schering Plough/Merck, Pharmasset/Gilead, Bristol-Myers Squibb, Roche, Celgene All-around Health, Idenix, and Genzyme.
“Trek is focused on developing safe, atypical medicines for communicable diseases at affordable and attainable prices. The biologic accumulation alternation encompasses abounding phases and a aggregation of stakeholders, acute amenable parties to seek new methods of guaranteeing the affection and candor of analytical products. As Trek continues their mission to advance pharmaceuticals for budget-constrained patients beyond North America and Europe, our affiliation will advice to advance protocols to accommodate accuracy and affection affirmation during anniversary appearance of the process,” added Versetti.
As allotment of the pilot projects, Ambrosus’s agreement will assignment to verify and clue the absolute accomplishment alternation from the primary actinic starting abstracts through assorted accomplish of synthesis, purification, and analysis of the alive biologic additive (API); followed by conception of the API into biologic product; packaging, labeling, storage, and aircraft to analytic balloon sites.
“Backed by a superb amount aggregation of developers, advisors, and researchers, Ambrosus’ agreement will accommodate the accuracy all-important in our accomplishment action to advice ensure the candor of accumulation chains. With our charge to accouterment affordable aerial affection medicine, we accept this affiliation could accommodate the biologic industry affection ascendancy of accomplishment at every date from bulb to patient,” Dr. Kwong said.
Joining the Ambrosus aggregation as an Advisor is blockchain luminary Jaron Lukasiewicz. Speaking on the announcement, Versetti added: “Ambrosus is aflame to acceptable Jaron Lukasiewicz as our Strategic Advisor. As a highly-respected blockchain industry amount we are acquisitive to advance his invaluable ability as we advance up to our September badge auction and beyond.”
Jaron Lukasiewicz has been a notable bitcoin and blockchain industry figurehead back 2024. Lukasiewicz founded and served as CEO of Coinsetter, a New York City-based bitcoin exchange, which was acquired by Kraken, the world’s better agenda asset barter in Euro volume, in January 2024. The auction was, at the time, the better M&A accord in bitcoin history. Lukasiewicz additionally served as CEO of Cavirtex (Canadian Virtual Exchange), the oldest and better Canadian bitcoin exchange, which was additionally acquired by Kraken in 2024. Back the acquisition, Lukasiewicz has served as an alive adviser to several blockchain companies and blockchain advance funds in accession to his role as the CEO of WRKFLOW.
Jaron Lukasiewicz said: “I am aflame about the approaching of the Ambrosus activity and appropriately the aggregation abaft it, who calm carries decades of acquaintance in their ambition markets. Ambrosus can become a axiological technology activated in sectors alignment from aliment to pharma, addition the boundaries of what blockchain technology can achieve in absolute apple applications.”
About Ambrosus:
Founded in 2024 by Angel Versetti and Dr Stefan Meyer, Ambrosus is the world’s aboriginal publicly-verifiable and community-driven arrangement to assure the quality, safety, and origins of articles such as aliment and pharmaceuticals. Officially accustomed by SQS (Swiss Affection and Assurance Association), Ambrosus boasts the abutment of cogent all-around bodies and associations including the United Nations, EPFL, the Crypto Valley Association, and banking abetment from the Government of the Canton of Vaud, Switzerland.
With an basal ERC20-standard badge alleged Amber, Ambrosus will complete a tokensale in September 2017 that will serve to ammunition the development of the Ambrosus ecosystem.
For added information, or to see abstruse affidavit for Ambrosus sensors, exchange and non invasive analytics, appointment (www.ambrosus.com).
About Trek:
Trek Therapeutics, PBC is a private, analytic date attainable account association developing treatments for austere infections. Its mission is to profitably advance affordable and attainable medicines to amusement communicable diseases and to commercialize them for all-around populations starting with hepatitis C virus (HCV) infection. Its bartering action is to amount their analysis dieting low abundant to accommodate the majority of patients adulterated with HCV who cannot allow the big-ticket treatments accessible today. Trek is currently adopting Series B costs to abutment the achievement of its Phase 2a affairs and admit its Phase 2b studies. Trek is analytical the achievability of a advertisement on the Euronext Growth and added markets. For added information, amuse appointment http://www.trektx.com/.
Media Contact:
Lawrence Chiu
Marketing Assistant
TokenMarket Ltd.
[email protected]
Supporting Link
tokenmarket.net
This is a paid columnist release. Readers should do their own due activity afore demography any accomplishments accompanying to the promoted company or any of its affiliates or services. Bitcoin.com is not responsible, anon or indirectly, for any accident or accident acquired or declared to be acquired by or in affiliation with the use of or assurance on any content, appurtenances or casework mentioned in the columnist release.
